Study in Journal of Mental Health and Clinic Psychology Confirms Freespira Drastically Reduces Panic Disorder Severity Freespira, Inc., the maker of the first FDA-cleared digital therapeutic to significantly reduce or eliminate symptoms of panic attacks,…
National Benchmark Study Supports BridgeHealth’s High-Value and High-Quality Surgical Focus Against $253 Billion in Medical Claims Paid by Self-Insured Employers Expert Reviews, Use of Appropriate Sites of Care and Centers of Excellence, and Strong Focus…
Breakthrough Multicentered Study will Evaluate Efficacy of Digital Health Data Collection Outside the Clinic for Guideline-Directed Heart Failure Therapy Datos Health, a leader in remote care automation, today announced its collaboration with Amgen, one of the…
Clinical Study Evaluates Efficacy and Potential Use of Nanomedic’s Electrospun Healing Fibers (EHF™) for Wounds and Burns Nanomedic Technologies, a leader in Electrospun Healing Fiber (EHF™) technology for wound healing and skin regeneration, today…
Helping government, hospitals, health plans, and pharmacies combat the U.S. mental health crisis and substance use epidemic Appriss Health, a technology company delivering point-of-care and data-sharing solutions addressing public health outcomes, announced the release of…
Pilot Study Aims to Assess Feasibility and Effectiveness of Monitoring Acute Cerebrovascular Accident Patients with Non-Invasive Continuous Monitoring Devices Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, has announced…
Study seeks to identify specific health concerns of rural communities in southeastern United States, with plans to use HemoScreen in Mobile Examination Unit (MEU) Lab PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care,…
VocalisCheck obtains CE mark (European Union) approval for medical use as a COVID-19 screening tool Vocalis Health, a company pioneering AI-based vocal biomarkers in healthcare, today announced results of a clinical study conducted in collaboration with…
Community is now enrolling participants in its COVID-19 home-based clinical study Current Health today launched Community, an initiative designed to glean deeper, more representative insights into human health at home. By using Current Health’s state-of-the-art health monitoring…
The funding will fuel the growth of Immunai’s proprietary AI-first single-cell drug discovery platform Immunai, a New York and Tel Aviv based biotech company, announced today $60M in funding, increasing the company’s total funding-to-date to…